1147557-79-6

Basic information

• Product Name: 2-fluoro-4-(1H-pyrazol-1-yl)aniline
• Synonyms: 2-fluoro-4-(1H-pyrazol-1-yl)aniline
• CAS NO: 1147557-79-6
• Molecular Weight: 177.181
• Mol File: 1147557-79-6.mol

Chemical Properties

• CAS DataBase Reference: 2-fluoro-4-(1H-pyrazol-1-yl)aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 2-fluoro-4-(1H-pyrazol-1-yl)aniline(1147557-79-6)
• EPA Substance Registry System: 2-fluoro-4-(1H-pyrazol-1-yl)aniline(1147557-79-6)

Safety Data

• Hazardous Substances Data: 1147557-79-6(Hazardous Substances Data)

Upstream product

• 288-13-1 NH-pyrazole 
• 29632-74-4 2-fluro-4-iodoaniline 

Downstream Products

• 1238704-28-3 3-acetyl-1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxypyridazin-4(1H)-one 
• 1357588-59-0 1-(3-bromofuran-2-yl)-2-{[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]hydrazono}butane-1,3-dione 

Relevant articles and documents

SUBSTITUTED 1, 6-NAPHTHYRIDINE INHIBITORS OF CDK5

Disclosed are compounds having structural formula I, and related salts and pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating diseases and conditions such as kidney disease, kidney failure, kidney stones, or polycystic kidney disease, using the compounds of formula (I), and related salts and pharmaceutical compositions.

Pyrazolopyrimidin CK2 and related heterocyclic compound as an inhibitor

The invention provides compounds that inhibit protein kinase CK2 activity (CK2 activity), and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and have the following general formula:

PRODUCTION METHOD OF PYRIDAZINONE COMPOUNDS

The present invention provides an industrially advantageous method of producing a pyridazinone compound. The present invention relates to the following method of producing a pyridazinone compound: Formula (II), (IIIa), (IV) or (IV ), Formula (IIIb), (Vb) or (V b), Formula (VI), (I) or (I ). wherein each symbol is as described in the specification.

BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Bicyclic Heterocycle Derivatives, compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.